Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) announced that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version of Janssen's antipsychotic agent Risperdal® (Risperidone) Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg. Shipment of these products has commenced.

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) announced that the Company has initiated patient enrollment in TARGET 1 and TARGET 2, its Phase 3, randomized, double-blind, placebo-controlled, multicenter studies to assess the efficacy and safety of rifaximin 550 mg, dosed three times daily, in the treatment of subjects with non-constipation irritable bowel syndrome (IBS).

Abviva, Inc. (OTCBB: AVVA) announced that BioBDC International (BioBDC), Abviva's exclusive sales agent for Mad Cow diagnostic tests produced by Abviva's subsidiary company Prion Developmental Laboratories, Inc.

GE Healthcare, the US$17 billion healthcare business of General Electric Company (GE), is working with medical leaders in the Olympic Movement to advance the use of innovative medical imaging technologies to provide insight into athlete health, as well as benefits for the general public.

Clostridium difficile infection (CDI) is a serious condition that causes disease with a wide spectrum of severity, ranging from mild diarrhea to pseudomembranous colitis and death. Recurrent CDI can occur in up to 20% of patients who develop an initial case of CDI.

Sunscreen has become a daily necessity for anyone spending time outdoors in the sun, especially during the hot summer months. Yet, very few people consider the protection afforded to them from their clothing. Clothing does protect the skin against the sun's harmful ultraviolet rays, but not all clothing provides the same protection.

Abbott announced that the U.S. Food and Drug Administration (FDA) approved the XIENCE(TM) V Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. XIENCE V is the only drug eluting stent to have demonstrated superiority over Boston Scientific's TAXUS(R) paclitaxel-eluting coronary stent system in two randomized head-to-head clinical trials.

Isolagen(TM), Inc. (Amex: ILE) announced the completion of the pivotal efficacy portion of its Phase III clinical studies (IT-R-005/006) investigating the Isolagen Therapy(TM) for the treatment of nasolabial folds, or wrinkles. The last person in each study has completed the primary efficacy follow-up visit, and collation of this data has begun.

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) reported that its lead product candidate bavituximab achieved the pre-specified Stage 1 primary endpoint in its ongoing Phase II clinical trial in patients with metastatic breast cancer.

Lyme disease may play a role in causing autism according to a recent study published in Medical Hypothesis, a peer-reviewed scientific journal. A team of five physicians led by Robert Bransfield, M.D., analyzed the two diseases and discovered a connection based on epidemiological findings, symptom similarities, case reports, and laboratory test results.

Discover the amazing future of health and nutrition through genetic and DNA testing - just out. This exciting new scientific breakthrough will make you look better, feel better, live longer and healthier lives. Learn the secrets and details about this health revolution, visit http://www.GeneWise4U.com which is completing their pre-launch campaign.

Now that school is out and the first day of summer is upon us, the cancer care experts at Texas Oncology remind Texans to "save your skin" by outsmarting the sun when spending time outdoors. Although the most prevalent cancer in the United States today, skin cancer is also the most preventable. The majority of the more than 1 million annual U.S. cases of skin cancer are sun-related.

Fully 96% of the US respondents to a recent morefocus group healthcare survey are concerned about the on-going effects of a nursing shortage. 84% believe that the Government should act now to increase nursing education access, while 65% of this group (55% of the total respondents), would be prepared to pay higher taxes.

The NPA has told PCTs planning new GP-led health centers to consider the impact on community pharmacy before rolling out plans for changes to their primary care infrastructure.

The EU Proposal for a Directive on patient's rights in cross border healthcare provides an added stimulus to the already growing number of medical tourists who seek hospital treatment elsewhere in the European Union. The Directive will create a formal framework and remove obstacles for UK patients wishing to travel for treatment in other EU countries.